Zinc-finger nuclease knockout of dual-specificity protein phosphatase-5 enhances the myogenic response and autoregulation of cerebral blood flow in FHH.1BN rats.
We recently reported that the myogenic responses of the renal afferent arteriole (Af-Art) and middle cerebral artery (MCA) and autoregulation of renal and cerebral blood flow (RBF and CBF) were impaired in Fawn Hooded hypertensive (FHH) rats and were restored in a FHH.1BN congenic strain in which a small segment of chromosome 1 from the Brown Norway (BN) containing 15 genes including dual-specificity protein phosphatase-5 (Dusp5) were transferred into the FHH genetic background. We identified 4 single nucleotide polymorphisms in the Dusp5 gene in FHH as compared with BN rats, two of which altered CpG sites and another that caused a G155R mutation. To determine whether Dusp5 contributes to the impaired myogenic response in FHH rats, we created a Dusp5 knockout (KO) rat in the FHH.1BN genetic background using a zinc-finger nuclease that introduced an 11 bp frame-shift deletion and a premature stop codon at AA121. The expression of Dusp5 was decreased and the levels of its substrates, phosphorylated ERK1/2 (p-ERK1/2), were enhanced in the KO rats. The diameter of the MCA decreased to a greater extent in Dusp5 KO rats than in FHH.1BN and FHH rats when the perfusion pressure was increased from 40 to 140 mmHg. CBF increased markedly in FHH rats when MAP was increased from 100 to 160 mmHg, and CBF was better autoregulated in the Dusp5 KO and FHH.1BN rats. The expression of Dusp5 was higher at the mRNA level but not at the protein level and the levels of p-ERK1/2 and p-PKC were lower in cerebral microvessels and brain tissue isolated from FHH than in FHH.1BN rats. These results indicate that Dusp5 modulates myogenic reactivity in the cerebral circulation and support the view that a mutation in Dusp5 may enhance Dusp5 activity and contribute to the impaired myogenic response in FHH rats.
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.
Fan
F
Fan
Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Aron M
AM
Geurts
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.
Mallikarjuna R
MR
Pabbidi
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.
Stanley V
SV
Smith
Department of Physiology and Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
David R
DR
Harder
Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Howard
H
Jacob
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.
Richard J
RJ
Roman
D000704:Analysis of Variance; D000818:Animals; D015153:Blotting, Western; D002560:Cerebrovascular Circulation / Q000235:genetics / Q000502:physiology*; D018389:Codon, Nonsense / Q000235:genetics; D017931:DNA Primers; D054637:Dual-Specificity Phosphatases / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000235:genetics*; D055786:Gene Knockout Techniques; D020768:Middle Cerebral Artery / Q000033:anatomy & histology; D024510:Muscle Development / Q000235:genetics / Q000502:physiology*; D010477:Perfusion; D011312:Pressure; D051381:Rats; D011922:Rats, Mutant Strains; D060888:Real-Time Polymerase Chain Reaction
D018389:Codon, Nonsense; D017931:DNA Primers; D054637:Dual-Specificity Phosphatases; C514214:Dusp5 protein, rat